OHT’s Dr. Arindam Nandi’s research shows that globally, Alzheimer’s disease costs the global economy around US$1.3 trillion for both medications and care, with much of the care being unpaid. Models reveal a shift in the burden of Alzheimer’s disease from high-income countries to low- and middle-income countries (LMICs). Data from LMICs, including India and China, reveal a higher proportion of unpaid care related to Alzheimer’s disease compared to paid care, which potentially prevents caregivers of Alzheimer’s patients from obtaining other jobs and decreases household economic output. [Health Policy Watch]
إرسال تعليق